Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment

Identifieur interne : 002E97 ( Main/Exploration ); précédent : 002E96; suivant : 002E98

Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment

Auteurs : Ronald A. Asherson [Royaume-Uni] ; David D'Cruz [Royaume-Uni] ; Catherine J. M. Stephens [Royaume-Uni] ; Phillip H. Mckee [Royaume-Uni] ; G. R. V. Hughes [Royaume-Uni]

Source :

RBID : ISTEX:2E46B3BB6AF54AFE50BCD59A76BE77D085796AC3

English descriptors

Abstract

Abstract: Findings in 27 patients with typical skin lesions of urticarial vasculitis (UV) who were seen at a connective tissue disease clinic over a 5-year period (1986 to 1990) are reviewed. The majority suffered from systemic lupus erythematosus (SLE) or from “lupus-like” disease (18 patients), 1 from “mixed” connective tissue disease (MCTD), and 5 from primary UV. All of the latter patients had normal serum complement levels (normocomplementemic urticarial vasculitic syndrome; NUVS). No patients with hypocomplementemic UV were encountered. Two patients suffered from necrotizing vasculitis (polyarteritis nodosa, Wegener's granulomatosis); one had a C1-esterase inhibitor deficiency and also demonstrated an immunoglobulin G paraproteinemia. Angioedema occurred in many patients and could not be used as a differential diagnostic feature. The course of the illness was chronic in most patients, lasting for up to 23 years, and the response to therapy was unpredictable, erratic, and unsustained. The use of intravenous “pulse” methylprednisolone, cyclophosphamide, or highdose oral steroids helped selected patients. Colchicine was dramatically effective in one patient with NUVS of 15 years duration. Azathioprine was not beneficial. None of the five patients with NUVS suffered from severe systemic involvement or renal disease, confirming observations by others that this form of UV represents a milder example of the condition.

Url:
DOI: 10.1016/0049-0172(91)90029-Y


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment</title>
<author>
<name sortKey="Asherson, Ronald A" sort="Asherson, Ronald A" uniqKey="Asherson R" first="Ronald A." last="Asherson">Ronald A. Asherson</name>
</author>
<author>
<name sortKey="D Cruz, David" sort="D Cruz, David" uniqKey="D Cruz D" first="David" last="D'Cruz">David D'Cruz</name>
</author>
<author>
<name sortKey="Stephens, Catherine J M" sort="Stephens, Catherine J M" uniqKey="Stephens C" first="Catherine J. M." last="Stephens">Catherine J. M. Stephens</name>
</author>
<author>
<name sortKey="Mckee, Phillip H" sort="Mckee, Phillip H" uniqKey="Mckee P" first="Phillip H." last="Mckee">Phillip H. Mckee</name>
</author>
<author>
<name sortKey="Hughes, G R V" sort="Hughes, G R V" uniqKey="Hughes G" first="G. R. V." last="Hughes">G. R. V. Hughes</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2E46B3BB6AF54AFE50BCD59A76BE77D085796AC3</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1016/0049-0172(91)90029-Y</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-J71DJ4RR-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000424</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000424</idno>
<idno type="wicri:Area/Istex/Curation">000424</idno>
<idno type="wicri:Area/Istex/Checkpoint">001C67</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001C67</idno>
<idno type="wicri:doubleKey">0049-0172:1991:Asherson R:urticarial:vasculitis:in</idno>
<idno type="wicri:Area/Main/Merge">002F64</idno>
<idno type="wicri:Area/Main/Curation">002E97</idno>
<idno type="wicri:Area/Main/Exploration">002E97</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment</title>
<author>
<name sortKey="Asherson, Ronald A" sort="Asherson, Ronald A" uniqKey="Asherson R" first="Ronald A." last="Asherson">Ronald A. Asherson</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>The Lupus Arthritis Research Unit, the Rayne Institute</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="D Cruz, David" sort="D Cruz, David" uniqKey="D Cruz D" first="David" last="D'Cruz">David D'Cruz</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>The Lupus Arthritis Research Unit, the Rayne Institute</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Stephens, Catherine J M" sort="Stephens, Catherine J M" uniqKey="Stephens C" first="Catherine J. M." last="Stephens">Catherine J. M. Stephens</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>The St John's Dermatology Centre</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mckee, Phillip H" sort="Mckee, Phillip H" uniqKey="Mckee P" first="Phillip H." last="Mckee">Phillip H. Mckee</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Department of Histopathology</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hughes, G R V" sort="Hughes, G R V" uniqKey="Hughes G" first="G. R. V." last="Hughes">G. R. V. Hughes</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>The Lupus Arthritis Research Unit, the Rayne Institute</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Seminars in Arthritis and Rheumatism</title>
<title level="j" type="abbrev">YSARH</title>
<idno type="ISSN">0049-0172</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1991">1991</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="285">285</biblScope>
<biblScope unit="page" to="296">296</biblScope>
</imprint>
<idno type="ISSN">0049-0172</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0049-0172</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Allergy</term>
<term>Angioedema</term>
<term>Arch dermatol</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Asherson</term>
<term>Azathioprine</term>
<term>Complement estimations</term>
<term>Connective tissue disease</term>
<term>Connective tissue disease clinic</term>
<term>Cutaneous</term>
<term>Cutaneous vasculitis</term>
<term>Cyclophosphamide</term>
<term>Dermatol</term>
<term>Dsdna</term>
<term>Erythema lesions</term>
<term>Erythematosus</term>
<term>Essential cryoglobulinemia</term>
<term>Esterase inhibitor deficiency</term>
<term>Family history</term>
<term>Huvs</term>
<term>Hydroxychloroquine</term>
<term>Hypocomplementaemic urticarial vasculitis syndrome</term>
<term>Immune</term>
<term>Immune complexes</term>
<term>Infectious mononucleosis</term>
<term>Inhibitor</term>
<term>Inhibitor deficiency</term>
<term>Lesion</term>
<term>Livedo reticularis</term>
<term>Lower limbs</term>
<term>Lupus</term>
<term>Lupus arthritis research unit</term>
<term>Mctd</term>
<term>Necrotizing</term>
<term>Necrotizing vasculitis</term>
<term>Oral corticosteroids</term>
<term>Oral steroids</term>
<term>Polyarteritis nodosa</term>
<term>Rash</term>
<term>Rayne institute</term>
<term>Renal disease</term>
<term>Retinal vasculitis</term>
<term>Serological features</term>
<term>Skin biopsy</term>
<term>Skin lesions</term>
<term>Steroid</term>
<term>Syndrome</term>
<term>Systemic</term>
<term>Systemic illness</term>
<term>Systemic lupus erythematosus</term>
<term>Urticaria</term>
<term>Urticarial</term>
<term>Urticarial lesions</term>
<term>Urticarial vasculitis</term>
<term>Vasculitis</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Findings in 27 patients with typical skin lesions of urticarial vasculitis (UV) who were seen at a connective tissue disease clinic over a 5-year period (1986 to 1990) are reviewed. The majority suffered from systemic lupus erythematosus (SLE) or from “lupus-like” disease (18 patients), 1 from “mixed” connective tissue disease (MCTD), and 5 from primary UV. All of the latter patients had normal serum complement levels (normocomplementemic urticarial vasculitic syndrome; NUVS). No patients with hypocomplementemic UV were encountered. Two patients suffered from necrotizing vasculitis (polyarteritis nodosa, Wegener's granulomatosis); one had a C1-esterase inhibitor deficiency and also demonstrated an immunoglobulin G paraproteinemia. Angioedema occurred in many patients and could not be used as a differential diagnostic feature. The course of the illness was chronic in most patients, lasting for up to 23 years, and the response to therapy was unpredictable, erratic, and unsustained. The use of intravenous “pulse” methylprednisolone, cyclophosphamide, or highdose oral steroids helped selected patients. Colchicine was dramatically effective in one patient with NUVS of 15 years duration. Azathioprine was not beneficial. None of the five patients with NUVS suffered from severe systemic involvement or renal disease, confirming observations by others that this form of UV represents a milder example of the condition.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
</region>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Asherson, Ronald A" sort="Asherson, Ronald A" uniqKey="Asherson R" first="Ronald A." last="Asherson">Ronald A. Asherson</name>
</region>
<name sortKey="D Cruz, David" sort="D Cruz, David" uniqKey="D Cruz D" first="David" last="D'Cruz">David D'Cruz</name>
<name sortKey="Hughes, G R V" sort="Hughes, G R V" uniqKey="Hughes G" first="G. R. V." last="Hughes">G. R. V. Hughes</name>
<name sortKey="Mckee, Phillip H" sort="Mckee, Phillip H" uniqKey="Mckee P" first="Phillip H." last="Mckee">Phillip H. Mckee</name>
<name sortKey="Stephens, Catherine J M" sort="Stephens, Catherine J M" uniqKey="Stephens C" first="Catherine J. M." last="Stephens">Catherine J. M. Stephens</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E97 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002E97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2E46B3BB6AF54AFE50BCD59A76BE77D085796AC3
   |texte=   Urticarial vasculitis in a connective tissue disease clinic: Patterns, presentations, and treatment
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021